Compare FURY & DH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FURY | DH |
|---|---|---|
| Founded | 2008 | 2011 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Precious Metals | Computer Software: Prepackaged Software |
| Sector | Basic Materials | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 115.8M | 112.1M |
| IPO Year | 2011 | 2021 |
| Metric | FURY | DH |
|---|---|---|
| Price | $0.57 | $1.02 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 2 | 5 |
| Target Price | $1.70 | ★ $3.08 |
| AVG Volume (30 Days) | 320.9K | ★ 796.5K |
| Earning Date | 08-11-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 63.28 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $241,521,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $0.74 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.50 | $0.61 |
| 52 Week High | $1.02 | $4.35 |
| Indicator | FURY | DH |
|---|---|---|
| Relative Strength Index (RSI) | 41.70 | 69.58 |
| Support Level | $0.51 | $0.93 |
| Resistance Level | $0.57 | $1.10 |
| Average True Range (ATR) | 0.03 | 0.07 |
| MACD | -0.01 | 0.02 |
| Stochastic Oscillator | 1.98 | 65.31 |
Fury Gold Mines Ltd is a Canadian-focused high-grade gold exploration company. The company's projects are strategically positioned in two prolific mining regions: the Eeyou Istchee James Bay Region of Quebec and the Kitikmeot Region in Nunavut. Fury Gold's project portfolio comprises the Committee Bay gold project in Nunavut, and the Eau Claire gold, Sakami gold, Elmer East gold and lithium, and Eleonore South gold projects in Quebec. Additionally, it also owns interests in the Kipawa rare earths project and has full ownership of the Zeus heavy rare earths project, both located in the Temiscamingue region of Quebec. The company operates in two reportable segments: Quebec and Nunavut.
Definitive Healthcare Corp is a provider of healthcare commercial intelligence. Its SaaS-based healthcare commercial intelligence platform is designed to provide comprehensive and accurate information on the healthcare ecosystem in the U.S. The platform uses deep analytics and data science to help customers develop data-driven strategic decisions, such as finding new markets to enter, building comprehensive go-to-market strategies, accessing tactical information to help target the right decision makers, and improving win rates with detailed contextual information. The company derives substantially all of its revenue from the sale of subscription fees for access to its platform and stand-ready support. Geographically, it derives a majority of its revenue from the United States.